[go: up one dir, main page]

AU2001279700A1 - 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect - Google Patents

5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect

Info

Publication number
AU2001279700A1
AU2001279700A1 AU2001279700A AU2001279700A AU2001279700A1 AU 2001279700 A1 AU2001279700 A1 AU 2001279700A1 AU 2001279700 A AU2001279700 A AU 2001279700A AU 2001279700 A AU2001279700 A AU 2001279700A AU 2001279700 A1 AU2001279700 A1 AU 2001279700A1
Authority
AU
Australia
Prior art keywords
pyrazolo
phosphodiesterase
pyrimidines
aminoalkyl
inhibiting effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001279700A
Other versions
AU2001279700B2 (en
Inventor
Norbert Beier
Maria Christadler
Rochus Jonas
Pierre Schelling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10031584A external-priority patent/DE10031584A1/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001279700A1 publication Critical patent/AU2001279700A1/en
Application granted granted Critical
Publication of AU2001279700B2 publication Critical patent/AU2001279700B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001279700A 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect Ceased AU2001279700B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031584A DE10031584A1 (en) 2000-06-29 2000-06-29 5-aminoalkyl-pyrazolo [4,3-d] pyrimidine
DE10031584.4 2000-06-29
PCT/EP2001/007378 WO2002000660A1 (en) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect

Publications (2)

Publication Number Publication Date
AU2001279700A1 true AU2001279700A1 (en) 2002-03-28
AU2001279700B2 AU2001279700B2 (en) 2006-08-24

Family

ID=7647151

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001279700A Ceased AU2001279700B2 (en) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
AU7970001A Pending AU7970001A (en) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU7970001A Pending AU7970001A (en) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect

Country Status (21)

Country Link
US (1) US7060823B2 (en)
EP (1) EP1296986B1 (en)
JP (1) JP4964388B2 (en)
KR (1) KR20030017558A (en)
CN (1) CN1439011A (en)
AR (1) AR028772A1 (en)
AT (1) ATE519761T1 (en)
AU (2) AU2001279700B2 (en)
BR (1) BR0111915A (en)
CA (1) CA2410399C (en)
CZ (1) CZ20024054A3 (en)
DE (1) DE10031584A1 (en)
ES (1) ES2367704T3 (en)
HU (1) HUP0301587A3 (en)
MX (1) MXPA02012263A (en)
NO (1) NO20026247D0 (en)
PL (1) PL358551A1 (en)
RU (1) RU2271359C2 (en)
SK (1) SK17632002A3 (en)
WO (1) WO2002000660A1 (en)
ZA (1) ZA200209728B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942474A1 (en) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo [4,3-d] pyrimidines
DE10031585A1 (en) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-aminoalkyl-thieno [2,3-d] pyrimidine
DE10058662A1 (en) * 2000-11-25 2002-05-29 Merck Patent Gmbh Use of pyrazolo [4,3-d] pyrimidines
CN100439371C (en) * 2003-04-29 2008-12-03 辉瑞大药厂 5,7-Diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
BRPI0409903A (en) 2003-04-29 2006-04-25 Pfizer Ltd 5,7-diamino pyrazol [4,3-d] pyrimidine useful in treating hypertension
GB0327319D0 (en) * 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
US7569572B2 (en) * 2004-04-07 2009-08-04 Pfizer Inc Pyrazolo[4,3-D]pyrimidines
EP1809632A2 (en) * 2004-10-28 2007-07-25 Pharmacia & Upjohn Company LLC Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors
PT1881985E (en) 2005-05-12 2011-02-01 Pfizer Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
NL2000291C2 (en) 2005-11-10 2009-02-17 Pfizer Prod Inc 1- (1- (2-ethoxyethyl) -3-ethyl-7- (4-methylpyridin-2-ylamino) -1 H -pyrazole (4,3-d) pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof.
DE102012200360A1 (en) * 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted triazines and their use
CA2782774A1 (en) * 2012-07-06 2014-01-06 Pharmascience Inc. Protein kinase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1739850A3 (en) * 1987-08-31 1992-06-07 Такеда Кемикал Индастриз, Лтд (Фирма) Method for synthesis of condensed derivatives of pyrazolo-[3,4-d]-pyrimidine
US5075310A (en) * 1988-07-01 1991-12-24 Smith Kline & French Laboratories, Ltd. Pyrimidone derivatives as bronchodilators
GB9119704D0 (en) * 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic agents
JP2657760B2 (en) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4-aminoquinazoline derivatives and pharmaceuticals containing them
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (en) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidines
DE19752952A1 (en) 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidines
DE19942474A1 (en) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo [4,3-d] pyrimidines

Similar Documents

Publication Publication Date Title
EP1416935B8 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
IL158697A0 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
SI1220856T1 (en) Pyrazolo(4,3-d)pyrimidine derivatives
AU2002221344A1 (en) Antiviral agents
HRP20020798A2 (en) 5-ALKYLPYRIDO[2,3-d]PYRIMIDINES TYROZINE KINASE INHIBITORS
EP1255764B8 (en) Purine derivatives
NO20022738D0 (en) Pyrrolo (2,3-d) pyrimidine
MXPA03002269A (en) Purine derivatives.
MXPA03000078A (en) Purine derivatives.
AU2003292007A1 (en) 4-AMINO-5-PHENYL-7-CYCLOHEXYL-PYRROLO(2,3-d)PYRIMIDINE DERIVATIVES
AU2001279700A1 (en) 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
AU7970001A (en) 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
MXPA03004453A (en) Pyrimidine derivatives.
AU2001236065A1 (en) Antiviral compounds
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
AU2002216033A1 (en) Use of pyrazolo(4,3-d)pyrimidines
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
AU8578501A (en) 2-aminoalkyl-thieno(2,3-d)pyrimidines
MXPA03000504A (en) Pyrimidine derivatives.
AU2001233026A1 (en) Phosphodiesterases
AU2002210526A1 (en) Substituted 3.4-dihydro-pyrido[1,2-A]pyrimidines
PL361915A1 (en) Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
AUPQ806700A0 (en) Antiviral agents